BCRP/ABCG2 Inhibitors
DBCAT002662Pharmacologic class
A DrugBank category of 198 drugs. 170 of them are approved.
- Also known as
- BCRP Inhibitor · BCRP inhibitors · BCRP/ABCG2-Inhibitors · Breast Cancer Resistance Protein Inhibitors
What you can answer from here — as of June 29, 2021
Which targets do BCRP/ABCG2 Inhibitors share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account